Toxicity evaluation of inorganic nanoparticles: Considerations and challenges

Molecular and Cellular Toxicology

Volumn 9, Issue 3, 2013, Pages 205-210

  Choi, Soo Jin ^a   Lee, Jong Kwon ^b   Jeong, Jayoung ^b   Choy, Jin Ho ^c  

^a Seoul Women University   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

^c Ewha Womans University   (South Korea)

Author keywords

Absorption mechanism; Inorganic nanoparticles; Physicochemical property; Physiological barriers; Toxicity

Indexed keywords

INORGANIC COMPOUND; NANOPARTICLE; SILICON DIOXIDE;

DISSOLUTION; EPITHELIUM CELL; HUMAN; INTESTINE ABSORPTION; NANOTOXICOLOGY; NONHUMAN; OPSONIZATION; PARTICLE SIZE; PHAGOCYTOSIS; PHYSICAL CHEMISTRY; RETICULOENDOTHELIAL SYSTEM; REVIEW; SKIN ABSORPTION; SURFACE CHARGE; TOXICITY;

EID: 84885413489     PISSN: 1738642X     EISSN: 20928467     Source Type: Journal    
DOI: 10.1007/s13273-013-0026-z     Document Type: Review

References (54)

1. Choi, S. J. & Choy, J. H. Layered double hydroxide nanoparticles as target-specific delivery carriers: uptake mechanism and toxicity. Nanomedicine (Lond) 6: 803-814 (2011).
2. Xia, T., Li, N. & Nel, A. E. Potential health impact of nanoparticles. Annu Rev Public Health 30:137-150 (2009).
3. Choi, S. J., Oh, J. M. & Choy, J. H. Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. J Inorg Biochem 103:463-471 (2009).
4. Fernandez, D., Garcia-Gomez, C. & Babin, M. In vitro evaluation of cellular responses induced by ZnO nanoparticles, zinc ions and bulk ZnO in fish cells. Sci Total Environ 452-453:262-274 (2013).
5. Cho, W. S. et al. Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part Fibre Toxicol 10:9 (2013).
6. Wang, J. et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett 168:176-185 (2007).
7. Khlebtsov, N. & Dykman, L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev 40:1647-1671 (2011).
8. Almeida, J. P., Chen, A. L., Foster, A. & Drezek, R. In vivo biodistribution of nanoparticles. Nanomedicine (Lond) 6:815-835 (2011).
9. Podila, R. & Brown, J. M. Toxicity of engineered nanomaterials: a physicochemical perspective. J Biochem Mol Toxicol 27:50-55 (2013).
10. Lai, D. Y. Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. WIRES Nanomed Nanobi 4:1-15 (2012).
11. Klien, K. & Godnic-Cvar, J. Genotoxicity of metal nanoparticles: focus on in vivo studies. Arh Hig Rada Toksikol 63:133-145 (2012).
12. Teeguarden, J. G. et al. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol Sci 95:300-312 (2007).
13. Campagnolo, L. et al. Physico-chemical properties mediating reproductive and developmental toxicity of engineered nanomaterials. Curr Med Chem 19:4488-4494 (2012).
14. Oberdorster, G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 267:89-105 (2010).
15. Lundqvist, M. et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. P Natl Acad Sci USA 105:14265-14270 (2008).
16. Sasidharan, N. P., Chandran, P. & Sudheer Khan, S. Interaction of colloidal zinc oxide nanoparticles with bovine serum albumin and its adsorption isotherms and kinetics. Colloid Surface B 102:195-201 (2013).
17. Lousinian, S., Missopolinou, D. & Panayiotou, C. Fibrinogen adsorption on zinc oxide nanoparticles: a Micro-Differential Scanning Calorimetry analysis. J Colloid Interf Sci 395:294-299 (2013).
18. Deng, Z. J. et al. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 20: 455101-455109 (2009).
19. Sharma, V. K. Aggregation and toxicity of titanium dioxide nanoparticles in aquatic environment-a review. J Environ Sci Health A Tox Hazard Subst Environ Eng 44:1485-1495 (2009).
20. Albanese, A., Tang, P. S. & Chan, W. C. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Ann Rev Biomed Eng 14:1-16 (2012).
21. Kendall, M. & Holgate, S. Health impact and toxicological effects of nanomaterials in the lung. Respirology 17:743-758 (2012).
22. Waalewijn-Kool, P. L., Ortiz, M. D., Lofts, S. & van Gestel, C. A. The effect of pH on the toxicity of ZnO nanoparticles to Folsomia candida in amended field soil. Environ Toxicol Chem DOI: 10.1002/etc.2302 (2013).
23. Misra, S. K. et al. The complexity of nanoparticle dissolution and its importance in nanotoxicological studies. Sci Total Environ 438:225-232 (2012).
24. Li, M., Lin, D. & Zhu, L. Effects of water chemistry on the dissolution of ZnO nanoparticles and their toxicity to Escherichia coli. Environ Pollut 173:97-102 (2013).
25. Mudunkotuwa, I. A., Rupasinghe, T., Wu, C. M. & Grassian, V. H. Dissolution of ZnO nanoparticles at circumneutral pH: a study of size effects in the presence and absence of citric acid. Langmuir 28:396-403 (2012).
26. Dobias, J. & Bernier-Latmani, R. Silver Release from Silver Nanoparticles in Natural Waters. Environ Sci Technol 47:4140-4146 (2013).
27. Loeschner, K. et al. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 8:18 (2011).
28. Gilbert, B. et al. The fate of ZnO nanoparticles administered to human bronchial epithelial cells. ACS nano 6:4921-4930 (2012).
29. Larner, F. et al. Tracing bioavailability of ZnO nanoparticles using stable isotope labeling. Environ Sci Technol 46:12137-12145 (2012).
30. Baek, M. et al. Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. Int J Nanomed 7:3081-3097 (2012).
31. 2 nanoparticles as a function of particle size. Environ Sci Technol 46:4909-4915 (2012).
32. Shahbazi, M. A. & Santos, H. A. Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication. Curr Drug Metab 14:28-56 (2013).
33. des Rieux, A. et al. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 116:1-27 (2006).
34. Park, K. et al. Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats. Arch Pharm Res 34:153-158 (2011).
35. Owens, D. E., 3rd & Peppas, N. A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93-102 (2006).
36. Longmire, M., Choyke, P. L. & Kobayashi, H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 3:703-717 (2008).
37. Choi, H. S. et al. Renal clearance of quantum dots. Nat Biotechnol 25:1165-1170 (2007).
38. Donaldson, K. & Poland, C. A. Inhaled nanoparticles and lung cancer - what we can learn from conventional particle toxicology. Swiss Med Wkly 142:w13547 (2012).
39. Klein, C. L. et al. Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies. Arch Toxicol 86:1137-1151 (2012).
40. Castranova, V. Overview of current toxicological knowledge of engineered nanoparticles. J Occup Environ Med 53:S14-17 (2011).
41. Crosera, M. et al. Nanoparticle dermal absorption and toxicity: a review of the literature. Int Arch Occ Env Hea 82:1043-1055 (2009).
42. Gulson, B. et al. Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol Sci 118:140-149 (2010).
43. Hirai, T. et al. Dermal absorption of amorphous nanosilica particles after topical exposure for three days. Pharmazie 67:742-743 (2012).
44. Ohlson, M., Sorensson, J. & Haraldsson, B. A gelmembrane model of glomerular charge and size selectivity in series. Am J Physiol-Renal 280:F396-405 (2001).
45. Xu, Z. P., Zeng, Q. H., Lu, G. Q. & Yu, A. B. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci 61:1027-1040 (2006).
46. Oh, J. M., Choi, S. J., Kim, S. T. & Choy, J. H. Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates: enhanced efficacy due to clathrinmediated endocytosis. Bioconjug Chem 17:1411-1417 (2006).
47. Doherty, G. J. & McMahon, H. T. Mechanisms of endocytosis. Annu Rev Biochem 78:857-902 (2009).
48. He, C., Yin, L., Tang, C. & Yin, C. Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs. Biomaterials 33:8569-8578 (2012).
49. van der Lubben, I. M., Verhoef, J. C., Borchard, G. & Junginger, H. E. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci 14:201-207 (2001).
50. Prego, C., Torres, D. & Alonso, M. J. The potential of chitosan for the oral administration of peptides. Expert Opin Drug Del 2:843-854 (2005).
51. Ishizawa, T., Hayashi, M. & Awazu, S. Paracellular and transcellular permeabilities of fosfomycin across small intestinal membrane of rat and rabbit by voltageclamp method. J Pharmacobiody 14:583-589 (1991).
52. Li, C. H. et al. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology 6:746-756 (2012).
53. Jenkins, J. T. et al. Excretion and toxicity of gold-iron nanoparticles. Nanomedicine 9:356-365 (2013).
54. Paek, H. J. et al. Modulation of the pharmacokinetics of zinc oxide nanoparticles and their fates in vivo. Nanoscale DOI: 10.1039/C3NR02140H (2013).